Marksans Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	9,897	4,958	4,033	3,824	2,064
Short-Term Investments	-	2,094	2,710	3,328	1,399
Trading Asset Securities	-	7.42	269.94	5.4	4.35
Cash & Short-Term Investments	9,897	7,060	7,013	7,158	3,467
Cash Growth	40.18%	0.67%	-2.03%	106.47%	63.19%
Accounts Receivable	6,446	5,400	4,532	4,168	3,948
Other Receivables	108.54	144.04	106.62	48.5	43.7
Receivables	6,554	5,544	4,638	4,217	3,991
Inventory	9,723	8,455	6,179	4,847	4,244
Prepaid Expenses	-	302.63	251.26	198.04	159.83
Other Current Assets	1,054	679.24	543.05	332.57	149.34
Total Current Assets	27,227	22,041	18,625	16,753	12,012
Property, Plant & Equipment	9,407	8,954	6,811	3,869	3,423
Long-Term Investments	-	1.68	1.68	-	-
Goodwill	452.56	409.28	394.99	384.89	300.25
Other Intangible Assets	1,168	727.32	647.62	707.97	585.69
Long-Term Deferred Tax Assets	129.65	-	-	-	38.57
Other Long-Term Assets	225.07	262.74	329.41	189.13	41.62
Total Assets	38,609	32,396	26,810	21,904	16,401
Accounts Payable	3,369	3,057	2,683	2,306	2,001
Accrued Expenses	3.18	644.31	442.56	220.96	131.01
Short-Term Debt	295.91	230.85	290.91	415.88	362.92
Current Portion of Long-Term Debt	-	-	-	-	50
Current Portion of Leases	436.58	354.92	249.51	156.68	280.52
Current Income Taxes Payable	415.83	299.41	199.08	252.78	173.27
Other Current Liabilities	750.31	186.91	33.66	57.59	563.67
Total Current Liabilities	5,271	4,773	3,898	3,410	3,562
Long-Term Leases	2,701	2,633	1,900	656.89	414.34
Pension & Post-Retirement Benefits	-	49.47	38.96	23.22	15.73
Long-Term Deferred Tax Liabilities	50.87	36.62	106.2	153.86	176.21
Other Long-Term Liabilities	59.15	9.73	6.63	9.3	2.83
Total Liabilities	8,082	7,503	5,950	4,253	4,171
Common Stock	453.16	453.16	453.16	453.16	409.31
Additional Paid-In Capital	-	5,045	5,045	5,045	1,732
Retained Earnings	-	17,358	13,827	10,913	8,230
Comprehensive Income & Other	29,778	1,813	1,326	1,040	1,651
Total Common Equity	30,232	24,669	20,651	17,452	12,023
Minority Interest	295.24	224.7	208.52	199.1	207.01
Shareholders' Equity	30,527	24,894	20,859	17,651	12,230
Total Liabilities & Equity	38,609	32,396	26,810	21,904	16,401
Total Debt	3,434	3,219	2,441	1,229	1,108
Net Cash (Debt)	6,463	3,841	4,572	5,929	2,359
Net Cash Growth	68.27%	-16.00%	-22.88%	151.30%	36.10%
Net Cash Per Share	14.26	8.48	10.09	14.27	5.76
Filing Date Shares Outstanding	452.99	453.16	453.16	453.16	409.31
Total Common Shares Outstanding	452.99	453.16	453.16	453.16	409.31
Working Capital	21,957	17,268	14,726	13,343	8,450
Book Value Per Share	66.74	54.44	45.57	38.51	29.37
Tangible Book Value	28,611	23,533	19,608	16,359	11,137
Tangible Book Value Per Share	63.16	51.93	43.27	36.10	27.21
Land	-	5.31	5.18	5.1	4.67
Buildings	-	2,815	2,287	1,633	1,511
Machinery	-	5,701	4,445	3,355	3,038
Construction In Progress	-	90	53.81	72.46	6.95
Leasehold Improvements	-	116.61	105.64	-	-